Biochemical Pharmacist Course

Lesson 1 • Signal Transduction Pathways

Introduces receptor-mediated signalling cascades and second messengers. Connects cellular communication to receptor-targeted pharmacology.

Lesson 2 • Amino Acids, Proteins, and Enzymes

Examines protein structure levels and enzyme catalysis mechanisms. Provides the basis for understanding enzyme-targeted medicines.

Lesson 3 • Nucleic Acids and Gene Expression

Explains DNA replication, transcription, and translation processes. Supports understanding of medicines targeting nucleic acid synthesis.

Lesson 4 • Carbohydrate and Lipid Biochemistry

Covers glycolysis, lipid metabolism, and energy production pathways. Links metabolic disruptions to pharmacological intervention points.

Lesson 1 • Renal and Biliary Medicine Excretion

Covers glomerular filtration, tubular secretion, and biliary elimination. Connects renal function to dose adjustment requirements.

Lesson 2 • Medicine Distribution in the Body

Examines volume of distribution, plasma protein binding, and tissue partitioning. Links physicochemical medicine properties to distribution patterns.

Lesson 3 • Compartmental Pharmacokinetic Modelling

Introduces one- and two-compartment models and key PK parameters. Enables calculation of half-life, clearance, and steady-state concentrations.

Lesson 4 • Medicine Absorption Mechanisms

Covers passive diffusion, active transport, and bioavailability factors. Establishes how route of administration affects medicine entry into systemic circulation.

Lesson 1 • Receptor Regulation and Tolerance

Explains receptor upregulation, downregulation, and desensitisation mechanisms. Links chronic medicine exposure to tolerance and withdrawal phenomena.

Lesson 2 • Therapeutic Index and Safety Margins

Defines therapeutic index, safety margin, and selectivity ratios. Applies these parameters to risk-benefit assessment in medicine therapy.

Lesson 3 • Medicine Interactions at the Receptor Level

Covers competitive, noncompetitive, and allosteric interactions between medicines. Prepares you to predict and manage pharmacodynamic medicine interactions.

Lesson 4 • Dose-Response Relationships

Examines graded and quantal dose-response curves and their parameters. Connects potency and efficacy measurements to clinical medicine selection.

Lesson 1 • Ion Channel Modulation by Medicines

Examines voltage-gated and ligand-gated channel pharmacology. Links channel blockade or activation to cardiovascular and neurological medicine effects.

Lesson 2 • Transporter Proteins as Medicine Targets

Covers neurotransmitter reuptake transporters and ABC transporter pharmacology. Explains how transporter inhibition or induction alters medicine and neurotransmitter levels.

Lesson 3 • Enzyme Inhibition as Medicine Mechanism

Covers competitive, irreversible, and suicide inhibition with clinical examples. Connects inhibitor kinetics to therapeutic and toxic outcomes.

Lesson 4 • Nucleic Acid-Targeted Medicine Mechanisms

Examines intercalation, alkylation, and topoisomerase inhibition strategies. Connects DNA-targeting mechanisms to antineoplastic and antimicrobial medicine classes.

Lesson 1 • Cytochrome P450 System in Depth

Covers CYP isoform specificity, induction, and inhibition with clinical relevance. Enables prediction of metabolic medicine-medicine interactions.

Lesson 2 • Prodrug Activation and Bioactivation

Covers enzymatic conversion of prodrugs to active forms and toxic bioactivation. Connects prodrug design to improved bioavailability and targeted delivery.

Lesson 3 • Genetic Polymorphisms in Medicine Metabolism

Examines poor, intermediate, extensive, and ultrarapid metaboliser phenotypes. Applies pharmacogenomic data to individualised dosing strategies.

Lesson 4 • Phase II Conjugation Reactions

Examines glucuronidation, sulfation, acetylation, and glutathione conjugation. Links conjugation capacity to individual variability in medicine clearance.

Lesson 1 • Immunological Medicine Reactions

Covers hapten formation, immune sensitisation, and hypersensitivity reaction types. Explains the biochemical basis of allergic and idiosyncratic medicine reactions.

Lesson 2 • Reactive Metabolites and Oxidative Stress

Covers reactive oxygen species generation, lipid peroxidation, and antioxidant defence. Links oxidative stress to hepatotoxicity and nephrotoxicity mechanisms.

Lesson 3 • Toxicokinetics and Dose-Toxicity Relationships

Covers toxicokinetic modelling, threshold doses, and nonlinear toxicity responses. Connects exposure metrics to risk assessment in clinical practice.

Lesson 4 • Genotoxicity and Carcinogenicity

Examines DNA adduct formation, mutagenesis, and carcinogen activation pathways. Applies genotoxicity testing principles to medicine safety evaluation.

Lesson 1 • Anti-Infective Medicine Biochemistry

Covers antibacterial, antiviral, antifungal, and antiparasitic mechanisms of action. Connects pathogen-specific biochemical targets to selective toxicity principles.

Lesson 2 • Cardiovascular and Metabolic Medicine Biochemistry

Covers statins, antihypertensives, antidiabetics, and antithrombotics at the molecular level. Links lipid, glucose, and coagulation biochemistry to medicine targets.

Lesson 3 • Anticancer Medicine Mechanisms

Examines cytotoxic agents, targeted kinase inhibitors, and immunotherapy biochemistry. Links tumour cell biology to medicine selectivity and resistance mechanisms.

Lesson 4 • Neuropsychiatric Medicine Mechanisms

Examines antidepressants, antipsychotics, anxiolytics, and analgesics at the receptor level. Connects neurotransmitter biochemistry to psychopharmacological medicine action.

Lesson 1 • Outcomes Evaluation and Pharmacovigilance

Covers adverse drug reaction reporting, outcomes measurement, and safety surveillance. Connects biochemical toxicity knowledge to real-world pharmacovigilance practice.

Lesson 2 • Therapeutic Drug Monitoring Principles

Covers target concentration ranges, sampling strategies, and assay interpretation. Applies TDM to narrow-therapeutic-index medicines in clinical settings.

Lesson 3 • Pharmacogenomics in Clinical Practice

Examines genotype-guided prescribing, biomarker testing, and clinical decision support. Connects genetic variation to individualised medicine selection and dosing.

Lesson 4 • Dosing in Special Populations

Examines paediatric, geriatric, renal, and hepatic impairment dosing adjustments. Applies physiological differences to pharmacokinetic parameter modification.